Cargando…
Exploring the Potential of Eltrombopag: Room for More?
Since its introduction in clinical practice, eltrombopag (ELT) has demonstrated efficacy in heterogeneous clinical contexts, encompassing both benign and malignant diseases, thus leading researchers to make a more in-depth study of its mechanism of action. As a result, a growing body of evidence dem...
Autores principales: | Tarantini, Francesco, Cumbo, Cosimo, Anelli, Luisa, Zagaria, Antonella, Conserva, Maria Rosa, Redavid, Immacolata, Specchia, Giorgina, Musto, Pellegrino, Albano, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168361/ https://www.ncbi.nlm.nih.gov/pubmed/35677428 http://dx.doi.org/10.3389/fphar.2022.906036 |
Ejemplares similares
-
Single-Cell Sequencing: Ariadne’s Thread in the Maze of Acute Myeloid Leukemia
por: Redavid, Immacolata, et al.
Publicado: (2022) -
Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?
por: Tarantini, Francesco, et al.
Publicado: (2021) -
Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick
por: Tarantini, Francesco, et al.
Publicado: (2021) -
IRF4 expression is low in Philadelphia negative myeloproliferative neoplasms and is associated with a worse prognosis
por: Cumbo, Cosimo, et al.
Publicado: (2021) -
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?
por: Conserva, Maria Rosa, et al.
Publicado: (2023)